These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34687957)

  • 1. Cartilage Oligomeric Matrix Protein, COMP may be a Better Prognostic Marker Than CEACAM5 and Correlates With Colon Cancer Molecular Subtypes, Tumor Aggressiveness and Overall Survival.
    Wusterbarth E; Chen Y; Jecius H; Krall E; Runyan RB; Pandey R; Nfonsam V
    J Surg Res; 2022 Feb; 270():169-177. PubMed ID: 34687957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing Incidence of Colon Cancer in the Young: Assessing the Tumor Biology.
    Nfonsam VN; Jecius H; Chen D; Omesiete PN; Ewongwo AN; Elquza E; Scott AJ; Jandova J
    J Am Coll Surg; 2019 Jul; 229(1):79-90. PubMed ID: 30995524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cartilage oligomeric matrix protein (COMP) promotes cell proliferation in early-onset colon cancer tumorigenesis.
    Nfonsam VN; Jecius HC; Janda J; Omesiete PN; Elquza E; Scott AJ; Nfonsam LE; Jandova J
    Surg Endosc; 2020 Sep; 34(9):3992-3998. PubMed ID: 31617091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
    Guo B; Wang Y; Liu W; Zhang S
    Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway.
    Liu TT; Liu XS; Zhang M; Liu XN; Zhu FX; Zhu FM; Ouyang SW; Li SB; Song CL; Sun HM; Lu S; Zhang Y; Lin J; Tang HM; Peng ZH
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1049-1063. PubMed ID: 29560517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COMP Gene Coexpresses With EMT Genes and Is Associated With Poor Survival in Colon Cancer Patients.
    Nfonsam VN; Nfonsam LE; Chen D; Omesiete PN; Cruz A; Runyan RB; Jandova J
    J Surg Res; 2019 Jan; 233():297-303. PubMed ID: 30502262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDX2 prognostic value in stage II/III resected colon cancer is related to CMS classification.
    Pilati C; Taieb J; Balogoun R; Marisa L; de Reyniès A; Laurent-Puig P
    Ann Oncol; 2017 May; 28(5):1032-1035. PubMed ID: 28328000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and clinical significance of CEACAM5 methylation in colorectal cancer patients.
    Huang SC; Chang SC; Liao TT; Yang MH
    Cancer Sci; 2024 Jan; 115(1):270-282. PubMed ID: 37942534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer.
    Englund E; Bartoschek M; Reitsma B; Jacobsson L; Escudero-Esparza A; Orimo A; Leandersson K; Hagerling C; Aspberg A; Storm P; Okroj M; Mulder H; Jirström K; Pietras K; Blom AM
    Oncogene; 2016 Oct; 35(43):5585-5596. PubMed ID: 27065333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.
    Marisa L; de Reyniès A; Duval A; Selves J; Gaub MP; Vescovo L; Etienne-Grimaldi MC; Schiappa R; Guenot D; Ayadi M; Kirzin S; Chazal M; Fléjou JF; Benchimol D; Berger A; Lagarde A; Pencreach E; Piard F; Elias D; Parc Y; Olschwang S; Milano G; Laurent-Puig P; Boige V
    PLoS Med; 2013; 10(5):e1001453. PubMed ID: 23700391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The myeloid cell biomarker EMR1 is ectopically expressed in colon cancer.
    Ali H; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Tumour Biol; 2021; 43(1):209-223. PubMed ID: 34486997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Consensus Molecular Subtypes and Molecular Markers With Clinical Outcomes in Patients With Metastatic Colorectal Cancer: Biomarker Analyses From LUME-Colon 1.
    Lenz HJ; Argiles G; Yoshino T; Tejpar S; Ciardiello F; Braunger J; Salnikov AV; Gabrielyan O; Schmid R; Höfler J; Kitzing T; Van Cutsem E
    Clin Colorectal Cancer; 2021 Mar; 20(1):84-95.e8. PubMed ID: 33041226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Cartilage Oligomeric Matrix Protein in colorectal cancer is an adverse prognostic factor and correlates negatively with infiltrating immune cells and PD-L1 expression.
    Blom AM; Gialeli C; Hagerling C; Berntsson J; Jirström K; Papadakos KS
    Front Immunol; 2023; 14():1167659. PubMed ID: 37207219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cartilage oligomeric matrix protein overexpression is an independent poor prognostic indicator in patients with intrahepatic cholangiocarcinoma.
    Ong KH; Hsieh YY; Lai HY; Sun DP; Chen TJ; Huang SK; Tian YF; Chou CL; Shiue YL; Wu HC; Chan TC; Tsai HH; Li CF; Su PA; Kuo YH
    Sci Rep; 2023 Oct; 13(1):17444. PubMed ID: 37838792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic subtypes predict outcomes in colorectal cancer.
    Kasurinen J; Beilmann-Lehtonen I; Kaprio T; Hagström J; Haglund C; Böckelman C
    Acta Oncol; 2023 Mar; 62(3):245-252. PubMed ID: 36867078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional proteomics of colon cancer Consensus Molecular Subtypes.
    Feliu J; Gámez-Pozo A; Martínez-Pérez D; Pérez-Wert P; Matamala-Luengo D; Viñal D; Kunz L; López-Vacas R; Dittmann A; Rodríguez-Salas N; Custodio A; Fresno Vara JÁ; Trilla-Fuertes L
    Br J Cancer; 2024 Jun; 130(10):1670-1678. PubMed ID: 38486123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FBW7 suppresses metastasis of colorectal cancer by inhibiting HIF1α/CEACAM5 functional axis.
    Li Q; Li Y; Li J; Ma Y; Dai W; Mo S; Xu Y; Li X; Cai S
    Int J Biol Sci; 2018; 14(7):726-735. PubMed ID: 29910683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of CEACAM5 as a Biomarker for Prewarning and Prognosis in Gastric Cancer.
    Zhou J; Fan X; Chen N; Zhou F; Dong J; Nie Y; Fan D
    J Histochem Cytochem; 2015 Dec; 63(12):922-30. PubMed ID: 26374829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRT19 and CEACAM5 mRNA-marked circulated tumor cells indicate unfavorable prognosis of breast cancer patients.
    Wang XM; Zhang Z; Pan LH; Cao XC; Xiao C
    Breast Cancer Res Treat; 2019 Apr; 174(2):375-385. PubMed ID: 30535933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer.
    Tarazona N; Gimeno-Valiente F; Gambardella V; Huerta M; Roselló S; Zuniga S; Calon A; Carbonell-Asins JA; Fontana E; Martinez-Ciarpaglini C; Eason K; Rentero-Garrido P; Fleitas T; Papaccio F; Moro-Valdezate D; Nyamundanda G; Castillo J; Espí A; Sadanandam A; Roda D; Cervantes A
    ESMO Open; 2020 Sep; 5(5):e000847. PubMed ID: 32967918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.